| 256 | 5 | 66 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 探讨通过胚胎形态学观察进行选择性卵裂期单胚胎移植策略优化的应用价值。方法 回顾性分析2019年6月至2020年10月在苏州市立医院生殖与遗传中心行IVF/ICSI-ET卵裂期胚胎新鲜周期移植或全胚冷冻保存后第1个冻融卵裂期胚胎移植患者的临床资料。根据患者是否进行受精后第2天(D2)胚胎形态学观察和胚胎移植数目分为:D2、D3连续观察卵裂期单胚胎移植组(连续观察单胚组)70个周期;无D2观察、仅D3观察卵裂期单胚胎移植组(D3观察单胚组)97个周期;仅D3观察卵裂期双胚胎移植组(D3观察DET组)564个周期。比较3组患者的一般资料、促排卵及胚胎发育实验室指标、临床妊娠率、种植率、异位妊娠率和早期自然流产率等,并采用多因素Logistic回归分析临床妊娠率的影响因素。结果 3组患者的年龄、体质量指数(BMI)、基础性激素水平、基础窦卵泡计数(AFC)等比较均无显著性差异(P>0.05)。3组患者的不同受精方式占比、Gn总量、HCG日内膜厚度、HCG日P水平、刺激天数均无显著性差异(P>0.05)。D3观察单胚组的获卵总数、成熟卵子数、2PN受精数、卵裂数、优胚数、成囊胚数显著低于其他两组(P<0.05),D3观察单胚组的临床妊娠率、HCG阳性率亦显著低于其他两组(P<0.05),连续观察单胚组的种植率显著高于其他两组(P<0.05);3组间的异位妊娠率、早期流产率无显著性差异(P>0.05)。连续观察单胚组和D3观察单胚组均无多胎妊娠发生,D3观察DET组的多胎妊娠率为42.37%(161/380)。采用多因素Logistic回归分析抗苗勒管激素(AMH)、HCG日E2水平、促排卵方案、获卵数、2PN受精数等对临床妊娠率的影响,结果显示各因素对临床妊娠率均无显著影响(P>0.05)。结论 对于年龄<35岁、卵巢储备功能正常的患者,进行D2、D3连续胚胎形态学观察后选择发育潜能最佳的胚胎行卵裂期单胚胎移植可以获得较理想的临床妊娠率,降低多胎妊娠率。
Abstract:Objective:To explore the application value of the optimal strategy for elective cleavage-stage single embryo transfer(SET) by the morphological observation.Methods:The clinical data of the first frozen-thawed embryo transfer after fresh cleavage-stage embryo transfer or whole embryo cryopreservation in the Center for Reproduction and Genetics, Suzhou Municipal Hospital from June 2019 to October 2020 were retrospectively analyzed. According to whether the embryo morphology was observed on the second day after fertilization(Day 2) and the number of embryos transferred, the IVF/ICSI-ET cycles were divided into three groups: Day 2 and Day 3 continuous morphological observation of SET group(continuous observation SET group, 70 cycles),no Day 2 observation, only Day 3 observation of SET group(Day 3 observation SET group, 97 cycles)and only Day 3 observation of double embryo transfer(DET) group(D3 observation DET group, 564 cycles). The general data, laboratory indicators of ovulation induction and embryonic development, clinical pregnancy rate, implantation rate, ectopic pregnancy rate and early miscarriage rate were compared among the three groups, and multivariate logistic regression was used to analyze the influencing factors of clinical pregnancy rate.Results:There were no significant differences in age, body mass index(BMI),basal sex hormone levels, and basal antral follicle count(AFC) among the three groups(P>0.05). There were no significant differences in the proportion of different fertilization methods, total dosage of Gn, endometrial thickness on HCG day, progesterone level on HCG day and stimulation days among the three groups(P>0.05). The numbers of oocytes retrieved, mature oocytes, 2 PN embryos, embryo cleavage, excellent embryos, and blastocyst formation in Day 3 observation SET group were significantly lower than those in the other two groups(P<0.05). The clinical pregnancy rate and HCG positive rate of Day 3 observation SET group were significantly lower than those of other groups(P<0.05). The implantation rate in continuous observation SET group was significantly higher than that of other groups(P<0.05). There was no significant difference in the rates of ectopic pregnancy and early miscarriage among the three groups(P>0.05). There was no multiple pregnancy in the continuous observation SET group and Day 3 observation SET group, and the multiple pregnancy rate in the Day 3 observation DET group was 42.37%(161/380). Multivariate logistic regression was used to analyze the effects of AMH,E2 levels on HCG Day, ovulation stimulation protocol, number of oocytes retrieved, number of 2 PN embryos, and clinical pregnancy rate. The results showed that each factor above had no significant effect on clinical pregnancy rate(P>0.05).Conclusions:For patients younger than 35 years old with good ovarian reserve, through Day 2 and Day 3 continuous embryo morphological observation, selecting the cleavage stage embryo with the best developmental potential for single embryo transfer can obtain an ideal clinical pregnancy rate and reduce the multiple pregnancy rate.
[1] 曹泽毅主编.中华妇产科学[M].第3版.北京:人民卫生出版社,2000:1874-1876.
[2] Lv H,Diao F,Du J,et al.Assisted reproductive technology and birth defects in a Chinese birth cohort study[J].Lancet Reg Health West Pac,2021,7:100090.
[3] American College of Obstetricians and Gynecologists’Committee on Practice Bulletins—Obstetrics,Society for Maternal-Fetal Medicine.Multifetal gestations:twin,triplet,and higher-order multifetal pregnancies:ACOG Practice Bulletin,Number 231[J].Obstet Gynecol,2021,137:e145-162.
[4] Deng K,Liang J,Mu Y,et al.Preterm births in China between 2012 and 2018:an observational study of more than 9 million women[J].Lancet Glob Health,2021,9:e1226-1241.
[5] Practice Committee of the American Society for Reproductive Medicine and the Practice Committee for the Society for Assisted Reproductive Technologies.Guidance on the limits to the number of embryos to transfer:a committee opinion[J].Fertil Steril,2021,116:651-654.
[6] European IVF-monitoring Consortium(EIM)? for the European Society of Human Reproduction and Embryology(ESHRE),Wyns C,Bergh C,et al.ART in Europe,2016:results generated from European registries by ESHRE[J].Hum Reprod,2020:2020:hoaa032.
[7] Harbottle S,Hughes C,Cutting R,et al.Elective single embryo transfer:an update to UK best practice guidelines[J].Hum Fertil(Camb),2015,18:165-183.
[8] K?llén B,Finnstr?m O,Lindam A,et al.Trends in delivery and neonatal outcome after in vitro fertilization in Sweden:data for 25 years[J].Hum Reprod,2010,25:1026-1034.
[9] 孙贻娟,黄国宁,孙海翔,等.关于胚胎移植数目的中国专家共识[J].生殖医学杂志,2018,27:940-945.
[10] Adamson GD,Norman RJ.Why are multiple pregnancy rates and single embryo transfer rates so different globally,and what do we do about it?[J].Fertil Steril,2020,114:680-689.
[11] 叶蓉华,张丽珠,杨孜,等.体外受精-胚胎移植后妊娠妇女的产科结局[J].中华妇产科杂志,2000,35:157-159.
[12] 李天凤,赵光临,帅振虹,等.辅助生殖技术单胎和双胎妊娠结局分析[J].现代医学,2020,48:1177-1180.
[13] Paulson RJ.Introduction:Frozen 2:an update on cryopreserved embryo transfer in the era of vitrification[J].Fertil Steril,2020,113:239-240.
[14] 刘丽,曹晓敏,张暄琳,等.选择性单胚胎移植策略探讨与临床结局分析[J].中华生殖与避孕杂志,2020,40:101-108.
[15] 周立花,符免艾,李娟.选择性单胚胎移植临床结局和可行性分析[J].重庆医学,2017,46:2116-2118.
[16] Pandian Z,Marjoribanks J,Ozturk O,et al.Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection[J].Cochrane Database Syst Rev,2013,2013:CD003416.
[17] Milewski R,Szpila M,Ajduk A.Dynamics of cytoplasm and cleavage divisions correlates with preimplantation embryo development[J].Reproduction,2018,155:1-14.
[18] Pribenszky C,Nilselid AM,Montag M.Time-lapse culture with morphokinetic embryo selection improves pregnancy and live birth chances and reduces early pregnancy loss:a meta-analysis[J/OL].Reprod Biomed Online,2017,35:511-520.
[19] Lee CI,Chen CH,Huang CC,et al.Embryo morphokinetics is potentially associated with clinical outcomes of single-embryo transfers in preimplantation genetic testing for aneuploidy cycles[J/OL].Reprod Biomed Online,2019,39:569-579.
[20] 郑爱燕,孟庆霞,丁洁,等.利用胚胎实时观测技术预测早期胚胎的发育潜能[J].生殖医学杂志,2018,27:957-961.
[21] 魏玉兰,靳镭,黄博,等.辅助生殖胚胎培养D2细胞数与卵裂期选择性单胚胎移植临床结局[J].中国计划生育学杂志,2020,28:2041-2044.
[22] Monson M,Silver RM.Multifetal gestation:mode of delivery[J].Clin Obstet Gynecol,2015,58:690-702.
[23] Riaz RM,Williams TR,Craig BM,et al.Cesarean scar ectopic pregnancy:imaging features,current treatment options,and clinical outcomes[J].Abdom Imaging,2015,40:2589-2599.
[24] Zhang N,Chen H,Xu Z,et al.Pregnancy,delivery,and neonatal outcomes of in vitro fertilization-embryo transfer in patient with previous cesarean scar[J].Med Sci Monit,2016,22:3288-3295.
[25] 罗敏,金力,刘欣燕,等.妊娠期瘢痕子宫破裂11例病例分析及文献复习[J].生殖医学杂志,2018,27:108-111.
[26] 乔宠,刘彩霞,赵扬玉.高龄妇女瘢痕子宫再妊娠管理专家共识(2021年版)[J].中国实用妇科与产科杂志,2021,37:558-563.
基本信息:
中图分类号:R714.8
引用信息:
[1]季玉娟,郑爱燕,丁洁,等.优化选择性卵裂期单胚胎移植策略的妊娠结局分析[J].生殖医学杂志,2022,31(08):1022-1029.
基金信息:
江苏省妇幼健康科研重点资助项目(F201820); 南京医科大学姑苏学院项目(GSKY20210226); 苏州市临床医学专家团队引进项目(SZYJTD201708)
2022-08-15
2022-08-15